Total Payments
$1,578
2023 Payments
$341.88
Companies
14
Transactions
32
Medicare Patients
5,502
Medicare Billing
$439,248
Payment Breakdown by Category
Food & Beverage$1,422 (90.1%)
Education$155.99 (9.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,422 | 30 | 90.1% |
| Education | $155.99 | 2 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $266.81 | 13 | $0 (2017) |
| Eli Lilly and Company | $226.26 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $182.35 | 4 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $167.87 | 3 | $0 (2022) |
| Abbott Laboratories | $157.62 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $124.74 | 1 | $0 (2023) |
| Amgen Inc. | $124.24 | 1 | $0 (2023) |
| ABIOMED | $108.41 | 1 | $0 (2018) |
| Boston Scientific Corporation | $77.58 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $54.58 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $341.88 | 4 | E.R. Squibb & Sons, L.L.C. ($124.74) |
| 2022 | $102.53 | 1 | Janssen Pharmaceuticals, Inc ($102.53) |
| 2021 | $157.62 | 1 | Abbott Laboratories ($157.62) |
| 2019 | $54.09 | 1 | Janssen Pharmaceuticals, Inc ($54.09) |
| 2018 | $264.40 | 3 | AstraZeneca Pharmaceuticals LP ($155.99) |
| 2017 | $657.15 | 22 | Novartis Pharmaceuticals Corporation ($266.81) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.24 | General |
| Category: Cardiology | ||||||
| 05/09/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $77.58 | General |
| Category: General - Therapies_IC | ||||||
| 04/20/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Cardiovascular | ||||||
| 09/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2021 | Abbott Laboratories | HeartMate 3 Left Ventricular Assist Device (Device) | Food and Beverage | In-kind items and services | $157.62 | General |
| Category: Heart Failure | ||||||
| 11/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $54.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $56.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/27/2018 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $108.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/02/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $90.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $54.58 | General |
| Category: NEPHROLOGY | ||||||
| 07/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/14/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $69.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2017 | Espero Pharmaceuticals, Inc. | GoNitro (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Angina | ||||||
| 05/18/2017 | Medicure Pharma Inc. | Aggrastat (tirofiban HCl) (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Acute cardiovascular care | ||||||
| 04/28/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,504 | 1,725 | $462,897 | $125,925 |
| 2022 | 16 | 1,254 | 1,403 | $342,181 | $94,737 |
| 2021 | 15 | 1,339 | 1,570 | $372,744 | $113,541 |
| 2020 | 15 | 1,405 | 1,606 | $377,634 | $105,045 |
Total Patients
5,502
Total Services
6,304
Medicare Billing
$439,248
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 251 | 283 | $120,275 | $40,253 | 33.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 201 | 307 | $67,233 | $30,111 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 137 | $43,840 | $9,995 | 22.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 151 | 151 | $65,081 | $7,672 | 11.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 86 | 106 | $16,218 | $6,852 | 42.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 51 | $14,790 | $5,152 | 34.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 37 | 42 | $14,742 | $3,700 | 25.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 40 | 41 | $21,484 | $3,531 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $13,200 | $2,945 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 25 | $11,775 | $2,876 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 42 | $9,114 | $2,110 | 23.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Office | 2023 | 25 | 25 | $13,100 | $2,058 | 15.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $7,774 | $1,931 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 31 | 31 | $13,361 | $1,548 | 11.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 83 | 83 | $3,901 | $1,173 | 30.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 145 | 163 | $2,934 | $965.48 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $3,520 | $887.37 | 25.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 14 | 14 | $5,712 | $663.12 | 11.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 41 | 42 | $4,788 | $600.18 | 12.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 27 | 27 | $3,078 | $371.54 | 12.1% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 12 | 12 | $2,568 | $221.87 | 8.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 14 | 14 | $434.00 | $126.39 | 29.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 47 | 48 | $2,544 | $117.12 | 4.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 27 | 27 | $1,431 | $63.44 | 4.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 192 | 203 | $83,636 | $32,046 | 38.3% |
About Dr. Daniel Walsh, MD
Dr. Daniel Walsh, MD is a Cardiovascular Disease healthcare provider based in Berkley, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114918620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Walsh, MD has received a total of $1,578 in payments from pharmaceutical and medical device companies, with $341.88 received in 2023. These payments were reported across 32 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,422).
As a Medicare-enrolled provider, Walsh has provided services to 5,502 Medicare beneficiaries, totaling 6,304 services with total Medicare billing of $439,248. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Berkley, MI
- Active Since 11/03/2005
- Last Updated 11/07/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114918620
Products in Payments
- ENTRESTO (Drug) $242.04
- BRILINTA (Drug) $182.35
- XARELTO (Drug) $167.87
- HeartMate 3 Left Ventricular Assist Device (Device) $157.62
- CAMZYOS (Drug) $124.74
- Repatha (Biological) $124.24
- Impella (Device) $108.41
- SAMSCA (Drug) $54.58
- GoNitro (Drug) $43.07
- TASIGNA (Drug) $24.77
- Aggrastat (tirofiban HCl) (Drug) $16.91
- Hillrom - Carnation Ambulatory Monitor (Device) $15.32
- PRADAXA (Drug) $11.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Berkley
Dr. Maher Rabah, Do, DO
Cardiovascular Disease — Payments: $3,854
Cardiovascular Disease $3,854
David Nori, Md, MD
Cardiovascular Disease — Payments: $1,246
Cardiovascular Disease $1,246
Dr. Rohit Vyas
Cardiovascular Disease — Payments: $762.47
Cardiovascular Disease $762.47
Dr. James Stewart, M.d, M.D
Cardiovascular Disease — Payments: $347.02
Cardiovascular Disease $347.02
Dr. Richard Gordon, D.o, D.O
Cardiovascular Disease — Payments: $336.29
Cardiovascular Disease $336.29
Sujana Gundlapalli, M.d, M.D
Cardiovascular Disease — Payments: $247.39
Cardiovascular Disease $247.39